Table 3

Distribution of HPV genotypes in HR-HC2 test positive women and overall population
HPV genotypes Number of infections HR-HC2 test positive women (N = 194), % Overall population* (N = 1094), %
16 60 30.9 5.5
31 38 19.6 3.5
66** 25 12.9 2.3
51 22 11.3 2.0
18 17 8.8 1.6
56 17 8.8 1.6
58 16 8.3 1.5
59 10 5.2 0.9
52 9 4.6 0.8
39 9 4.6 0.8
45 8 4.1 0.7
53** 7 3.6 0.6
33 6 3.1 0.5
68 6 3.1 0.5
73** 3 1.5 0.3
35 2 1.0 0.2
82** 1 0.5 0.1
26** 0 0.0 0.0

* HPV type-specific prevalence has been extrapolated to overall population although it should be stressed that the genotyping was performed only on HR-HC2 positive samples.

** The prevalence of HPV 26,53,66,73,82 is probably underestimated because these HPV types are detected by the “Consensus High Risk HPV genotyping” assay, but they are not targeted by the HR-HC2 test.

Giambi et al.

Giambi et al. BMC Infectious Diseases 2013 13:74   doi:10.1186/1471-2334-13-74

Open Data